A marker for Stevens-Johnson syndrome …: ethnicity matters

A marker for Stevens–Johnson syndrome

Wen‐Hung Chung, Hong‐Shang Hong, Mo‐Song Hsih et al. · Nature · 2004 · 1.7K citations

Life Sciences, Dermatology, Hypersensitivity +3

Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis

Jean‐Claude Roujeau, Judith P. Kelly, Luigi Naldi et al. · New England Journal of Medicine · 1995 · 1.5K citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

S. Mallal, David Nolan, Campbell S. Witt et al. · The Lancet · 2002 · 1.4K citations

Life Sciences, Immunology, Infectious Diseases +12

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Wen‐Hung Chung, Lieh-Bang Liou, C.C. Chu et al. · Proceedings of the National Academy of Sciences · 2005 · 1.3K citations

Life Sciences, Genetics, Immunology +12

Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin

I. Viard, Philippe Wehrli, Roberto Bullani et al. · Science · 1998 · 1K citations

Life Sciences, Immunology, Pharmacology +12